Evidence map›Paper›PMID 39477950›Full record

ArticleNature communications2024

Encoding extracellular modification of artificial cell membranes using engineered self-translocating proteins.

Alexander Harjung, Alessandro Fracassi, Neal K Devaraj

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Towards origins of virtual artificial life: an overview.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alexander HarjungDepartment of Chemistry and Biochemistry, University of California, San Diego, CA, USA.ORCID 0009-0002-4219-4686
Alessandro FracassiDepartment of Chemistry and Biochemistry, University of California, San Diego, CA, USA.ORCID 0000-0003-1239-6527
Neal K DevarajDepartment of Chemistry and Biochemistry, University of California, San Diego, CA, USA. ndevaraj@UCSD.edu.ORCID 0000-0002-8033-9973

Funding

U.S. Department of Defense (United States Department of Defense) N00014-22-1-2800
6 · The paper itself

Abstract

The development of artificial cells has led to fundamental insights into the functional processes of living cells while simultaneously paving the way for transformative applications in biotechnology and medicine. A common method of generating artificial cells is to encapsulate protein expression systems within lipid vesicles. However, to communicate with the external environment, protein translocation across lipid membranes must take place. In living cells, protein transport across membranes is achieved with the aid of complex translocase systems which are difficult to reconstitute into artificial cells. Thus, there is need for simple mechanisms by which proteins can be encoded and expressed inside synthetic compartments yet still be externally displayed. Here we present a genetically encodable membrane functionalization system based on mutants of pore-forming proteins. We modify the membrane translocating loop of α-hemolysin to translocate functional peptides up to 52 amino acids across lipid membranes. Full membrane translocation occurs in the absence of any translocase machinery and the translocated peptides are recognized by specific peptide-binding ligands on the opposing membrane side. Engineered hemolysins can be used for genetically programming artificial cells to display interacting peptide pairs, enabling their assembly into artificial tissue-like structures.

Indexed as

Artificial CellsCell MembraneHemolysin ProteinsProtein EngineeringProtein TransportEscherichia coliEscherichia coli ProteinsMembranes, ArtificialPeptidesEscherichia coli ProteinsHemolysin ProteinsMembranes, ArtificialPeptides

Identifiers

PMID39477950
PMCPMC11526174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.